Gene delivery targeted to oligodendrocytes using a lentiviral vector

Journal of Gene Medicine

Volumn 16, Issue 11-12, 2014, Pages 364-373

  Kagiava, Alexia ^a   Sargiannidou, Irene ^a   Bashiardes, Stavros ^a   Richter, Jan ^a   Schiza, Natasa ^a   Christodoulou, Christina ^a   Gritti, Angela ^b   Kleopa, Kleopas A ^a  

^a CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

^b SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

Author keywords

CNP promoter; EGFP; Gene therapy; Leukodystrophy

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; ENHANCED GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; GREEN FLUORESCENT PROTEIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CELL MIGRATION; CELL POPULATION; COCULTURE; CONTROLLED STUDY; CORPUS CALLOSUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HIPPOCAMPUS; IMMUNOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; LATERAL BRAIN VENTRICLE; MALE; MOUSE; MYELINATION; NEWBORN; NONHUMAN; OLFACTORY BULB; OLIGODENDROCYTE PRECURSOR CELL; OLIGODENDROGLIA; PROTEIN EXPRESSION; SCHWANN CELL; SCIATIC NERVE; STRATUM RADIATUM; SUBVENTRICULAR ZONE; TARGET CELL; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; ANIMAL; BIOSYNTHESIS; BRAIN; C57BL MOUSE; GENE THERAPY; GENE VECTOR; GENETICS; LENTIVIRINAE; METABOLISM; PC12 CELL LINE; RAT;

ANIMALS; BRAIN; COCULTURE TECHNIQUES; FEMALE; GENE EXPRESSION; GENETIC THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; LENTIVIRUS; MALE; MICE, INBRED C57BL; OLIGODENDROGLIA; PC12 CELLS; RATS; SCIATIC NERVE;

EID: 84916606169     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.2813     Document Type: Article

References (57)

1. Huang X, Yang Y. Innate immune recognition of viruses and viral vectors. Hum Gene Ther 2009; 20: 293-301.
2. von Jonquieres G, Mersmann N, Klugmann CB, et al. Glial promoter selectivity following AAV-delivery to the immature brain. PLoS One 2013; 8: e65646.
3. Broekman ML, Comer LA, Hyman BT, et al. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain. Neuroscience 2006; 138: 501-510.
4. Consiglio A, Gritti A, Dolcetta D, et al. Robust in vivo gene transfer into adult mammalian neural stem cells by lentiviral vectors. Proc Natl Acad Sci U S A 2004; 101: 14835-14840.
5. Consiglio A, Quattrini A, Martino S, et al. In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice. Nat Med 2001; 7: 310-316.
6. Naldini L, Blomer U, Gage FH, et al. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci U S A 1996; 93: 11382-11388.
7. Kaplitt MG, Leone P, Samulski RJ, et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 1994; 8: 148-154.
8. Markakis EA, Vives KP, Bober J, et al. Comparative transduction efficiency of AAV vector serotypes 1-6 in the substantia nigra and striatum of the primate brain. Mol Ther 2010; 18: 588-593.
9. Lattanzi A, Neri M, Maderna C, et al. Widespread enzymatic correction of CNS tissues by a single intracerebral injection of therapeutic lentiviral vector in leukodystrophy mouse models. Hum Mol Genet 2010; 19: 2208-2227.
10. Geraerts M, Eggermont K, Hernandez-Acosta P, et al. Lentiviral vectors mediate efficient and stable gene transfer in adult neural stem cells in vivo. Hum Gene Ther 2006; 17: 635-650.
11. Lattanzi A, Gentner B, Corno D, et al. Dynamic activity of miR-125b and miR-93 during murine neural stem cell differentiation and in the subventricular zone neurogenic niche. PLoS One 2013; 8: e67411.
12. Dong JY, Fan PD, Frizzell RA. Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. Hum Gene Ther 1996; 7: 2101-2112.
13. Simonato M, Bennett J, Boulis NM, et al. Progress in gene therapy for neurological disorders. Nat Rev Neurol 2013; 9: 277-291.
14. Azzouz M, Martin-Rendon E, Barber RD, et al. Multicistronic lentiviral vector-mediated striatal gene transfer of aromatic L-amino acid decarboxylase, tyrosine hydroxylase, and GTP cyclohydrolase I induces sustained transgene expression, dopamine production, and functional improvement in a rat model of Parkinson's disease. J Neurosci 2002; 22: 10302-10312.
15. Lundberg C, Bjorklund T, Carlsson T, et al. Applications of lentiviral vectors for biology and gene therapy of neurological disorders. Curr Gene Ther 2008; 8: 461-473.
16. Lattanzi A, Salvagno C, Maderna C, et al. Therapeutic benefit of lentiviral-mediated neonatal intracerebral gene therapy in a mouse model of globoid cell leukodystrophy. Hum Mol Genet 2014; 23: 3250-3268.
17. McIver SR, Lee CS, Lee JM, et al. Lentiviral transduction of murine oligodendrocytes in vivo. J Neurosci Res 2005; 82: 397-403.
18. Chen H, McCarty DM, Bruce AT, et al. Oligodendrocyte-specific gene expression in mouse brain: use of a myelin-forming cell type-specific promoter in an adeno-associated virus. J Neurosci Res 1999; 55: 504-513.
19. Lawlor PA, Bland RJ, Mouravlev A, et al. Efficient gene delivery and selective transduction of glial cells in the mammalian brain by AAV serotypes isolated from nonhuman primates. Mol Ther 2009; 17: 1692-1702.
20. Gravel M, Di Polo A, Valera PB, et al. Four-kilobase sequence of the mouse CNP gene directs spatial and temporal expression of lacZ in transgenic mice. J Neurosci Res 1998; 53: 393-404.
21. Sargiannidou I, Vavlitou N, Aristodemou S, et al. Connexin32 mutations cause loss of function in Schwann cells and oligodendrocytes leading to PNS and CNS myelination defects. J Neurosci 2009; 29: 4736-4749.
22. Forghani R, Garofalo L, Foran DR, et al. A distal upstream enhancer from the myelin basic protein gene regulates expression in myelin-forming schwann cells. J Neurosci 2001; 21: 3780-3787.
23. Mathis C, Hindelang C, LeMeur M, et al. A transgenic mouse model for inducible and reversible dysmyelination. J Neurosci 2000; 20: 7698-7705.
24. Tress O, Maglione M, Zlomuzica A, et al. Pathologic and phenotypic alterations in a mouse expressing a connexin47 missense mutation that causes Pelizaeus-Merzbacher-like disease in humans. PLoS Genet 2011; 7: e1002146.
25. Uhlenberg B, Schuelke M, Ruschendorf F, et al. Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus-Merzbacher-like disease. Am J Hum Genet 2004; 75: 251-260.
26. Dull T, Zufferey R, Kelly M, et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998; 72: 8463-8471.
27. Sango K, Kawakami E, Yanagisawa H, et al. Myelination in coculture of established neuronal and Schwann cell lines. Histochem Cell Biol 2012; 137: 829-839.
28. Scherer SS, Braun PE, Grinspan J, et al. Differential regulation of the 2', 3'-cyclic nucleotide 3'-phosphodiesterase gene during oligodendrocyte development. Neuron 1994; 12: 1363-1375.
29. Iizuka A, Takayama K, Torashima T, et al. Lentiviral vector-mediated rescue of motor behaviour in spontaneously occurring hereditary ataxic mice. Neurobiol Dis 2009; 35: 457-465.
30. Pilpel N, Landeck N, Klugmann M, et al. Rapid, reproducible transduction of select forebrain regions by targeted recombinant virus injection into the neonatal mouse brain. J Neurosci Methods 2009; 182: 55-63.
31. Palfi S, Gurruchaga JM, Ralph GS, et al. Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial. Lancet 2014; 383: 1138-1146.
32. McGarrity GJ, Hoyah G, Winemiller A, et al. Patient monitoring and follow-up in lentiviral clinical trials. J Gene Med 2013; 15: 78-82.
33. Cronin J, Zhang XY, Reiser J. Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther 2005; 5: 387-398.
34. Cetin A, Komai S, Eliava M, et al. Stereotaxic gene delivery in the rodent brain. Nat Protoc 2006; 1: 3166-3173.
35. Pencea V, Bingaman KD, Freedman LJ, et al. Neurogenesis in the subventricular zone and rostral migratory stream of the neonatal and adult primate forebrain. Exp Neurol 2001; 172: 1-16.
36. Gritti A, Bonfanti L, Doetsch F, et al. Multipotent neural stem cells reside into the rostral extension and olfactory bulb of adult rodents. J Neurosci 2002; 22: 437-445.
37. Chen H, McCarty DM, Bruce AT, et al. Gene transfer and expression in oligodendrocytes under the control of myelin basic protein transcriptional control region mediated by adeno-associated virus. Gene Ther 1998; 5: 50-58.
38. Yuan X, Chittajallu R, Belachew S, et al. Expression of the green fluorescent protein in the oligodendrocyte lineage: a transgenic mouse for developmental and physiological studies. J Neurosci Res 2002; 70: 529-545.
39. Linterman KS, Palmer DN, Kay GW, et al. Lentiviral-mediated gene transfer to the sheep brain: implications for gene therapy in Batten disease. Hum Gene Ther 2011; 22: 1011-1020.
40. Belachew S, Chittajallu R, Aguirre AA, et al. Postnatal NG2 proteoglycan-expressing progenitor cells are intrinsically multipotent and generate functional neurons. J Cell Biol 2003; 161: 169-186.
41. Doetsch F, Caille I, Lim DA, et al. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 1999; 97: 703-716.
42. Levison SW, Goldman JE. Both oligodendrocytes and astrocytes develop from progenitors in the subventricular zone of postnatal rat forebrain. Neuron 1993; 10: 201-212.
43. Temple S. The development of neural stem cells. Nature 2001; 414: 112-117.
44. Aguirre AA, Chittajallu R, Belachew S, et al. NG2-expressing cells in the subventricular zone are type C-like cells and contribute to interneuron generation in the postnatal hippocampus. J Cell Biol 2004; 165: 575-589.
45. Biffi A, Aubourg P, Cartier N. Gene therapy for leukodystrophies. Hum Mol Genet 2011; 20: R42-53.
46. Weinberg MS, Samulski RJ, McCown TJ. Adeno-associated virus (AAV) gene therapy for neurological disease. Neuropharmacology 2013; 69: 82-88.
47. Sargiannidou I, Markoullis K, Kleopa KA. Molecular mechanisms of gap junction mutations in myelinating cells. Histol Histopathol 2010; 25: 1191-1206.
48. Scherer SS, Xu YT, Messing A, et al. Transgenic expression of human connexin32 in myelinating Schwann cells prevents demyelination in connexin32-null mice. J Neurosci 2005; 25: 1550-1559.
49. Giaume C, Koulakoff A, Roux L, et al. Astroglial networks: a step further in neuroglial and gliovascular interactions. Nat Rev Neurosci 2010; 11: 87-99.
50. Pfeuty B, Mato G, Golomb D, et al. The combined effects of inhibitory and electrical synapses in synchrony. Neural Comput 2005; 17: 633-670.
51. Menichella DM, Goodenough DA, Sirkowski E, et al. Connexins are critical for normal myelination in the CNS. J Neurosci 2003; 23: 5963-5973.
52. Odermatt B, Wellershaus K, Wallraff A, et al. Connexin 47 (Cx47)-deficient mice with enhanced green fluorescent protein reporter gene reveal predominant oligodendrocytic expression of Cx47 and display vacuolized myelin in the CNS. J Neurosci 2003; 23: 4549-4559.
53. Bugiani M, Al Shahwan S, Lamantea E, et al. GJA12 mutations in children with recessive hypomyelinating leukoencephalopathy. Neurology 2006; 67: 273-279.
54. Bilir B, Yapici Z, Yalcinkaya C, et al. High frequency of GJA12/GJC2 mutations in Turkish patients with Pelizaeus-Merzbacher disease. Clin Genet 2013; 83: 66-72.
55. Martino S, Marconi P, Tancini B, et al. A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease. Hum Mol Genet 2005; 14: 2113-2123.
56. Jeyakumar M, Dwek RA, Butters TD, et al. Storage solutions: treating lysosomal disorders of the brain. Nat Rev Neurosci 2005; 6: 713-725.
57. Jeyakumar M, Lee JP, Sibson NR, et al. Neural stem cell transplantation benefits a monogenic neurometabolic disorder during the symptomatic phase of disease. Stem Cells 2009; 27: 2362-2370.